Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.64 |
| ▸ | HTR6 | P50406 | 16/20 | 0.53 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.41 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9695585 | 0.98 | HTR2A (0.62) | HTR2AHTR6SCN9ATAAR1OPRM1 | |
| Ammonia Solution, Strong SCHEMBL28037069 | 0.98 | HTR2A (0.62) | HTR2AHTR6SCN9ATAAR1OPRM1 | |
| Carbamic Acid SCHEMBL28875082 | 0.92 | HTR2A (0.55) | HTR2AHTR6SCN9A | |
| Fumaric Acid SCHEMBL6273999 | 0.88 | HTR2A (0.51) | HTR2AHTR6SCN9A | |
| SCHEMBL20674511 | 0.80 | GPR84 (0.44) | HTR2AOPRM1OPRL1 | |
| SCHEMBL7561915 | 0.79 | HTR2A (0.66) | HTR2AHTR6SCN9ATAAR1 | |
| Serotonin SCHEMBL14991266 | 0.79 | HTR2C (0.67) | HTR2AHTR6TAAR1 | |
| SCHEMBL7037223 | 0.79 | HTR2A (0.60) | HTR2AHTR6SCN9A | |
| SCHEMBL25166949 | 0.78 | HTR2A (0.64) | HTR2AHTR6SCN9ATAAR1OPRM1 | |
| SCHEMBL6787250 | 0.78 | HTR2A (0.64) | HTR2AHTR6SCN9ATAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4364 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118490733-B | Ant colony algorithm-back propagation neural network-based extraction process for optimizing safflower seeds | ZHEJIANG CHINESE MEDICAL UNIVERSITY (CN) | 2026-05-26 | — | — | CN | claimed |
| US-20260132218-A1 | FULLY HUMAN MONOCLONAL ANTIBODIES AGAINST HUMAN HER-2 | A & G PHARMACEUTICAL INC (US) | 2026-05-14 | — | — | US | claimed |
| EP-4172145-B1 | TRYPTAMINE PRODRUGS AS SEROTONIN RECEPTOR ACTIVATORS FOR THE TREATMENT OF E.G. DEPRESSION | REUNION NEUROSCIENCE INC (US) | 2026-05-13 | — | — | EP | claimed |
| EP-4695300-A2 | ANTIBODIES AND CONJUGATES AGAINST PROSTAGLANDIN F2 RECEPTOR INHIBITOR AND USES THEREOF | A & G Pharmaceutical, Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4638757-A1 | METHODS FOR THE PRODUCTION OF TRYPTOPHAN DERIVATIVES | Natural Medtech Pty Ltd (AU) | 2025-10-29 | — | — | EP | claimed |
| US-20250154237-A1 | FULLY HUMAN MONOCLONAL ANTIBODIES AGAINST HUMAN PROGRANULIN | A & G PHARMACEUTICAL, INC. | 2025-05-15 | — | — | US | claimed |
| US-20250051278-A1 | TRYPTAMINE PRODRUGS | REUNION NEUROSCIENCE INC. (CA) | 2025-02-13 | — | — | US | claimed |
| CN-119285526-A | Tryptamine prodrugs | 瑞安神经科学公司 | 2025-01-10 | — | — | CN | claimed |
| CN-119285527-A | Tryptamine prodrugs | 瑞安神经科学公司 | 2025-01-10 | — | — | CN | claimed |
| EP-4482861-A2 | FULLY HUMAN MONOCLONAL ANTIBODIES AGAINST HUMAN PROGRANULIN | A & G Pharmaceutical, Inc. (US) | 2025-01-01 | — | — | EP | claimed |
| CN-1036441-C | Technology for raising poultry | NANJING AGRICULTURAL UNIVERSITY (CN) | 1997-11-19 | — | — | CN | claimed |
| EP-0792179-A1 | DEVICE FOR THE TRANSDERMAL ADMINISTRATION OF MEDICAMENTS TO TREAT THE MALE ERECTILE IMPOTENCE | LABORATOIRES D'HYGIENE ET DE DIETETIQUE L.H.D. Société Anonyme dite: (FR) | 1997-09-03 | — | — | EP | claimed |
| WO-1997011159-A1 | YEAST RECEPTOR AND G-PROTEIN FUSION PROTEIN | MOLECULAR GERIATRICS CORPORATION (US) | 1997-03-27 | — | — | WO | claimed |
| WO-1996014897-A1 | DEVICE FOR THE TRANSDERMAL ADMINISTRATION OF MEDICAMENTS TO TREAT THE MALE ERECTILE IMPOTENCE | LABORATOIRES D'HYGIENE ET DE DIETETIQUE (L.H.D.) (FR) | 1996-05-23 | — | — | WO | claimed |
| WO-1996001107-A1 | USE OF PHARMACEUTICAL AGENTS FOR RESTORING, ALLEVIATION, OR TREATMENT OF IMMUNODEFICIENCY, INCLUDING THE ALLEVIATION OR TREATMENT OF THE IMMUNE DYSFUNCTION RELATED TO INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUSES (HIV) OR RELATED VIRUSES | HOFMANN BO ARNE (DK) | 1996-01-18 | — | — | WO | claimed |
| WO-1996001106-A1 | USE OF PHARMACEUTICAL AGENTS FOR ALLEVIATION OR TREATMENT OF THE IMMUNE DYSFUNCTION RELATED TO INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUSES (HIV) OR RELATED VIRUSES | HOFMANN BO ARNE (DK) | 1996-01-18 | — | — | WO | claimed |
| CN-1082891-A | Technology for raising poultry | UNIV NANJING AGRICULTURAL (CN) | 1994-03-02 | — | — | CN | claimed |
| CN-1047974-A | Compositions and methods for effecting contraception | COHEN MICHAEL (NL) | 1990-12-26 | — | — | CN | claimed |
| US-4428880-A | Azepino[4,5-d]indole derivatives and preparation thereof | S.A. OMNICHEM (BE) | 1984-01-31 | — | — | US | claimed |
| US-4144133-A | OXGALL, SAPONIN, SUBSTRATE FOR PHENOL OXIDASE | J. K. AND SUSIE L. WADLEY RESEARCH INSTITUTE AND BLOOD BANK (US) | 1979-03-13 | — | — | US | claimed |